iShares Biotechnology ETF Newsroom

Vir Gets FDA Breakthrough Therapy Status for Two Drugs

Seeking Alpha06:03

Unpacking the Latest Options Trading Trends in Amgen

Benzinga03:16

Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing

Benzinga02:13

Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $261

Benzinga01:22 · Ratings

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

MT NewswiresDec 12 22:07

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday as Traders Pull Back in Anticipation of More Inflation Data

MT NewswiresDec 12 21:26

10 Health Care Stocks Whale Activity In Today's Session

BenzingaDec 12 01:35

RBC Capital Reiterates Outperform on IQVIA Hldgs, Maintains $270 Price Target

BenzingaDec 11 23:43 · Ratings

RBC Capital Reiterates Sector Perform on Gilead Sciences, Maintains $84 Price Target

BenzingaDec 11 23:42 · Ratings

BioNTech Analyst Ratings

BenzingaDec 11 22:54 · Ratings

Sector Update: Health Care Stocks Edge Higher Pre-Bell Wednesday

MT NewswiresDec 11 22:22

This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

BenzingaDec 11 21:35

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday as Investors Anticipate Latest Inflation Data

MT NewswiresDec 11 21:24

This Owens Corning Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

BenzingaDec 11 21:08

Illumina Analyst Ratings

BenzingaDec 11 20:22 · Ratings

Mettler-Toledo Intl Analyst Ratings

BenzingaDec 11 20:20 · Ratings

IQVIA Hldgs Analyst Ratings

BenzingaDec 11 20:16 · Ratings

BofA Restarts Coverage of 11 Large-cap Biopharmas

Seeking AlphaDec 11 06:01

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaDec 11 01:35

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday

MT NewswiresDec 10 22:07